Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has provided an update.
Daito Pharmaceutical Co., Ltd. announced the repurchase of 36,300 shares of its own common stock for a total of 77,881,300 yen, conducted through market purchases on the Tokyo Stock Exchange. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 300,000 shares, aiming to enhance shareholder value and optimize capital structure.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
YTD Price Performance: 4.55%
Average Trading Volume: 35,628
Technical Sentiment Signal: Sell
Current Market Cap: Yen34.72B
See more insights into 4577 stock on TipRanks’ Stock Analysis page.